AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (388.1 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data

Yufei Jiang1,2,3,*Huiyun Yuan2,3,*Zhuoying Li1,2,3Xiaowei Ji1,2,3Qiuming Shen1,2,3Jiayi Tuo1,2,3Jinghao Bi1,2,3Honglan Li1,2Yongbing Xiang1,2,3 ( )
State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200032, China
Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

*These authors contributed equally to this work.

Show Author Information

Abstract

This review will describe the global patterns and trends of colorectal cancer survival, using data from the population-based studies or cancer registration. We performed a systematic search of China National Knowledge Infrastructure (CNKI), Wanfang Data, PubMed, Web of Science, EMBASE, and SEER and collected all population-based survival studies of colorectal cancer (up to June 2020). Estimates of observed and relative survival rates of colorectal cancer by sex, period, and country were extracted from original studies to describe the temporal patterns and trends from the late 1990s to the early 21st century. Globally, 5-year observed survival rates were higher in Seoul, Republic of Korea (1993–1997; 56.8% and 54.3% for colon and rectum cancers, respectively), Zhejiang province (2005–2010; 52.9% for colon cancer), Tianjin (1991–1999; 52.5% for colon cancer), Shanghai (2002–2006; 50.0% for rectum cancer) of China, and in Japan (1993–1996, 59.6% for colorectal cancer). Five-year relative survival rates of colorectal cancer in the Republic of Korea (2010–2014), Queensland, Australia (2005–2012), and the USA (2005–2009) ranked at relatively higher positions compared to other countries. In general, colorectal cancer survival rates are improving over time worldwide. Sex disparities in survival rates were also observed in the colon, rectum, and colorectal cancers in most countries or regions. The poorest age-specific 5-year relative survival rate was observed in patients > 75 years of age. In conclusion, over the past 3 decades, colorectal cancer survival has gradually improved. Geographic variations, sex differences, and age gradients were also observed globally in colorectal cancer survival. Further studies are therefore warranted to investigate the prognostic factors of colorectal cancer.

Electronic Supplementary Material

Download File(s)
cbm-19-2-175_ESM.pdf (106.4 KB)

References

1

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71: 209-49.

2

Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017; 66: 683-91.

3

Science CHCAoM. Chinese Guideline for Cancer Registration (2016) ed. Beijing: People’s Medical Publishing House(PMPH); 2016.

4

Jiang YF, Li ZY, Ji XW, Shen QM, Tuo JY, Yuan HY, et al. Global pattern and trend of liver cancer survival: a systematic review of population-based studies. Hepatoma Res. 2020; 6: 52.

5

Pietrantonio F, Morano F, Corallo S, Miceli R, Lonardi S, Raimondi A, et al. Maintenance therapy with panitumumab alone vs panitumumab plus fluorouracil-leucovorin in patients with RAS wild-type metastatic colorectal cancer: a phase 2 randomized clinical trial. JAMA Oncol. 2019; 5: 1268-75.

6

Fang YJ, Wu XJ, Zhao Q, Li LR, Lu ZH, Ding PR, et al. Hospitalbased colorectal cancer survival trend of different tumor locations from 1960s to 2000s. PLoS One. 2013; 8: e73528.

7

Gong YM, Wu CX, Zhang ML, Peng P, Gu K, Bao PP, et al. Colorectal cancer survival analysis in major areas in shanghai China. China Oncol. 2015; 25: 497-504.

8

Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods. Acta Oncol. 2010; 49: 545-60.

9

Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004; 40: 2307-16.

10

Ellison LF. Adjusting relative survival estimates for cancer mortality in the general population. Health Rep. 2014; 25: 3-9.

11

Innos K, Lang K, Pärna K, Aareleid T. Age-specific cancer survival in Estonia: recent trends and data quality. Clin Epidemiol. 2015; 7: 355-62.

12

Chirlaque MD, Salmeron D, Galceran J, Ameijide A, Mateos A, Torrella A, et al. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries. Clin Transl Oncol. 2018; 20: 201-11.

13

Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, et al. Survival from colorectal cancer in Germany in the early 21st century. Br J Cancer. 2012; 106: 1875-80.

14

Pavlik T, Majek O, Buchler T, Vyzula R, Petera J, Ryska M, et al. Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008. Cancer Epidemiol. 2014; 38: 28-34.

15

Ellison LF, Wilkins K. An update on cancer survival. Health Rep. 2010; 21: 55-60.

16

Brenner H, Hakulinen T. Up-to-date and precise estimates of cancer patient survival: model-based period analysis. Am J Epidemiol. 2006; 164: 689-96.

17

Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Brenner H. Cancer survival differences between European countries and an urban population from the Philippines. Eur J Public Health. 2011; 21: 221-8.

18

Sankaranarayanan R, Swaminathan R, Lucas E, Brenner H, Ganesh B, Mathew A, et al. Cancer Survival in Africa, Asia, the Caribbean and Central America (IARC Scientific Publications; 162). Lyon: International Agency for Research on Cancer; 2011: 23-257.

19

Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011; 377: 127-38.

20

Zeng H, Zheng R, Guo Y, Zhang S, Zou X, Wang N, et al. Cancer survival in China, 2003–2005: a population- based study. Int J Cancer. 2015; 136: 1921-30.

21

Coleman MP, Quaresma M, Berrino F, Lutz J-M, De Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008; 9: 730-56.

22

Gondos A, Arndt V, Holleczek B, Stegmaier C, Ziegler H, Brenner H. Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer. 2007; 121: 395-400.

23

Chirlaque MD, Salmeron D, Ardanaz E, Galceran J, Martinez R, Marcos-Gragera R, et al. Cancer survival in Spain: estimate for nine major cancers. Ann Oncol. 2010; 21: iii21-29.

24

Birgisson H, Talbäck M, Gunnarsson U, Påhlman L, Glimelius B. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol. 2005; 31: 845-53.

25

Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Uy G, Brenner H. Inter-country and ethnic variation in colorectal cancer survival: comparisons between a Philippine population, Filipino-Americans and Caucasians. BMC Cancer. 2010; 10: 100.

26

Brenner H, Hakulinen T. Long-term cancer patient survival achieved by the end of the 20th century: most up-to-date estimates from the nationwide Finnish cancer registry. Br J Cancer. 2001; 85: 367-71.

27

Ellison LF. Measuring the effect of including multiple cancers in survival analyses using data from the Canadian Cancer Registry. Cancer Epidemiol. 2010; 34: 550-5.

28

Holleczek B, Rossi S, Domenic A, Innos K, Minicozzi P, Francisci S, et al. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007-Results from the EUROCARE-5 study. Eur J Cancer. 2015; 51: 2158-68.

29

Iversen LH, Pedersen L, Riis A, Friis S, Laurberg S, Sorensen HT. Population-based study of short- and long-term survival from colorectal cancer in Denmark, 1977–1999. Br J Surg. 2005; 92: 873-80.

30

Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, Sobue T. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol. 2011; 41: 40-51.

31

Jansen L, Castro FA, Gondos A, Krilaviciute A, Barnes B, Eberle A, et al. Recent cancer survival in Germany: an analysis of common and less common cancers. Int J Cancer. 2015; 136: 2649-58.

32

Innos K, Reima H, Baburin A, Paapsi K, Aareleid T, Soplepmann J. Subsite- and stage-specific colorectal cancer trends in Estonia prior to implementation of screening. Cancer Epidemiol. 2018; 52: 112-9.

33

Innos K, Soplepmann J, Suuroja T, Melnik P, Aareleid T. Survival for colon and rectal cancer in Estonia: role of staging and treatment. Acta Oncol. 2012; 51: 521-7.

34

Hiripi E, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, et al. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol. 2012; 23: 472-55.

35

Tsukuma H, Ajiki W, Ioka A, Oshima A. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol. 2006; 36: 602-7.

36

Li Y, Yu L, Na J, Li S, Liu L, Mu H, et al. Survival of cancer patients in northeast China: analysis of sampled cancers from population-based cancer registries. Cancer Res Treat. 2017; 49: 1106-13.

37

Jung KW, Won YJ, Kong HJ, Oh CM, Shin A, Lee JS. Survival of Korean adult cancer patients by stage at diagnosis, 2006–2010: National Cancer Registry Study. Cancer Res Treat. 2013; 45: 162-71.

38

Yang YJ, Bae JM. Survival rates of the 5 major cancers in Jeju Island residents, 2000–2001. J Prev Med Public Health. 2007; 40: 213-7.

39

Chen YS, Ding LL, Zhang YH, Zhu J, Chen JG. Survival of colorectum cancer cases in 2001–2007 in Qidong city, Jiangsu province, China. China Oncol. 2011; 21: 134-9.

40

Luo SL, Gong WW, Wang H, Pan J, Fei FR, Yu M. Survival rate of colorectal cancer patients during 2005-2010 in zhejiang province, China. China J Epidemiol. 2013; 34: 1194-7.

41

Zhou J, Su X, Li L, Yu LS, Wu YL, Wang YY, et al. Survival rate among the main cancer patients in three countys of GuiZhou province, 2013–2015. Stud Trace Elem Health. 2020; 37: 54-6.

42

He YT, Zeng Y, Xu H, Song GH, Tian G, Chen C, et al. Survival rate among cancer patients in Cixian county, 2000–2002. China J Public Health. 2011; 27: 1107-10.

43

Chen JG, Zhu J, Zhang YH, Zhang YX, Yao DF, Chen YS, et al. Cancer survival in Qidong between 1972 and 2011: a population-based analysis. Mol Clin Oncol. 2017; 6: 944-54.

44

Phimha S, Promthet S, Suwanrungruang K, Chindaprasirt J, Bouphan P, Santong C, et al. Health insurance and colorectal cancer survival in Khon Kaen, Thailand. Asian Pac J Cancer Prev. 2019; 20: 1797-802.

45

Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al. EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary. Ann Oncol. 2003; 14(Suppl. 5): v61-118.

46

Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer. 2009; 45: 931-91.

47

Penninckx F, Van Eycken L, Michiels G, Mertens R, Bertrand C, De Coninck D, et al. Survival of rectal cancer patients in Belgium 1997–98 and the potential benefit of a national project. Acta Chir Belg. 2006; 106: 149-57.

48

El Mistiri M, Salati M, Marcheselli L, Attia A, Habil S, Alhomri F, et al Cancer incidence, mortality, and survival in Eastern Libya: updated report from the Benghazi Cancer Registry. Ann Epidemiol. 2015; 25: 564-8.

49

Gondos A, Brenner H, Wabinga H, Parkin DM. Cancer survival in Kampala, Uganda. Br J Cancer. 2005; 92: 1808-12.

50

Lemmens V, van Steenbergen L, Janssen-Heijnen M, Martijn H, Rutten H, Coebergh JW. Trends in colorectal cancer in the south of the Netherlands 1975–2007: rectal cancer survival levels with colon cancer survival. Acta Oncol. 2010; 49: 784-96.

51

Brenner H, Francisci S, de Angelis R, Marcos-Gragera R, Verdecchia A, Gatta G, et al. Long-term survival expectations of cancer patients in Europe in 2000–2002. Eur J Cancer. 2009; 45: 1028-41.

52

Krilaviciute A, Smailyte G, Brenner H, Gondos A. Cancer survival in Lithuania after the restoration of independence: rapid improvements, but persisting major gaps. Acta Oncol. 2014; 53: 1238-44.

53

Iversen LH, Green A, Ingeholm P, Osterlind K, Gogenur I. Improved survival of colorectal cancer in Denmark during 2001–2012-The efforts of several national initiatives. Acta Oncologica. 2016; 55: 10-23.

54
Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, et al. SEER Cancer Statistics Review, 1975-2017, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020.
55

Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson AB, et al. Annual report to the nation on the status of cancer, 1975–2014, featuring survival. J Natl Cancer Inst. 2017; 109: djx030.

56

Ortiz-Ortiz KJ, Ramirez-Garcia R, Cruz-Correa M, Rios-Gonzalez MY, Ortiz AP. Effects of type of health insurance coverage on colorectal cancer survival in Puerto Rico: a population-based study. Plos One. 2014; 9: e96746.

57

Cramb SM, Moraga P, Mengersen KL, Baade PD. Spatial variation in cancer incidence and survival over time across Queensland, Australia. Spat Spatiotemporal Epidemiol. 2017; 23: 59-67.

58

Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012; 44: 11-24.

59

Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014; 46: 109-23.

60

Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, Lee KH. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat. 2017; 49: 292-305.

61

Jung KW, Won YJ, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016. Cancer Res Treat. 2019; 51: 417-30.

62

Hur H, Oh C-M, Won Y-J, Oh JH, Kim NK. Characteristics and survival of Korean patients with colorectal cancer based on data from the Korea central cancer registry data. Ann Coloproctol. 2018; 34: 212-21.

63

Chiang CJ, Lo WC, Yang YW, You SL, Chen CJ, Lai MS. Incidence and survival of adult cancer patients in Taiwan, 2002–2012. J Formos Med Assoc. 2016; 115: 1076-88.

64

Zeng HM, Chen WQ, Zheng RS, Zhang SW, Ji JS, Zou XN, X, et al. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018; 6: e555-67.

65

Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, et al Colorectal cancer screening: a global overview of existing programmes. Gut. 2015; 64: 1637-49.

66

Brenner H, Bouvier AM, Foschi R, Hackl M, Larsen IK, Lemmens V, et al, Group EW. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study. Int J Cancer. 2012; 131: 1649-58.

67

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893-17.

68

Baili P, Di Salvo F, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, et al. Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: results of EUROCARE-5, a population-based study. Eur J Cancer. 2015; 51: 2120-9.

69

Walters S, Benitez-Majano S, Muller P, Coleman MP, Allemani C, Butler J, et al. Is England closing the international gap in cancer survival? Br J Cancer. 2015; 113: 848-60.

70

Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009; 59: 366-78.

71

Macek P, Biskup M, Ciepiela P, Terek-Derszniak M, Sosnowska-Pasiarska B, Krol H, et al. Changes in survival of colorectal cancer patients in Swietokrzyskie Province (Southern Poland) from the second half of the 1990s to the early 21st century - a population-based study. Ann Agric Environ Med. 2020; 27: 301-5.

72

Micheli A, Ciampichini R, Oberaigner W, Ciccolallo L, de Vries E, Izarzugaza I, et al, Group EW. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer. 2009; 45: 1017-27.

73

Kerr J, Engel J, Eckel R, Hölzel D. Survival for rectal cancer patients and international comparisons. Ann Oncol. 2005; 16: 664-72.

74

Laudico AV, Mirasol-Lumague MR, Mapua CA, Uy GB, Toral JAB, Medina VM, et al. Cancer incidence and survival in metro manila and rizal province, Philippines. Jpn J Clin Oncol. 2010; 40: 603-12.

75

Visser O, van Leeuwen FE. Stage-specific survival of epithelial cancers in North-Holland/Flevoland, The Netherlands. Eur J Cancer. 2005; 41: 2321-30.

76

Jemal A, Clegg LX, Ward E, Ries LAG, Wu XC, Jamison PM, et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer. 2004; 101: 3-27.

77

Campbell J, Gandhi K, Pate A, Janitz A, Anderson A, Kinnard R, et al. Five-year cancer survival rates in Oklahoma from 1997 to 2008. J Okla State Med Assoc. 2016; 109: 318-32.

78

Gondos A, Bray F, Brewster DH, Coebergh JWW, Hakulinen T, Janssen-Heijnen MLG, et al. Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. Eur J Cancer. 2008; 44: 1463-75.

79

Lake J, Mak V, Moller H, Davies EA. Variation, precision and validity of 1-year survival estimates for lung, breast, colon and prostate cancer in South East England primary care trusts. Public Health. 2012; 126: 57-63.

Cancer Biology & Medicine
Pages 175-186
Cite this article:
Jiang Y, Yuan H, Li Z, et al. Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data. Cancer Biology & Medicine, 2022, 19(2): 175-186. https://doi.org/10.20892/j.issn.2095-3941.2020.0634

43

Views

0

Downloads

24

Crossref

44

Web of Science

43

Scopus

Altmetrics

Received: 10 October 2020
Accepted: 25 April 2021
Published: 29 March 2022
©2022 Cancer Biology & Medicine.

Creative Commons Attribution-NonCommercial 4.0 International License

Return